Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 157 to 159 of 159 entries
Sorted by: Best Match Show Resources per page
Nutrient History Affects the Response and Resilience of the Tropical Seagrass .

Frontiers in plant science

Helber SB, Winters G, Stuhr M, Belshe EF, Bröhl S, Schmid M, Reuter H, Teichberg M.
PMID: 34421939
Front Plant Sci. 2021 Aug 05;12:678341. doi: 10.3389/fpls.2021.678341. eCollection 2021.

Eutrophication is one of the main threats to seagrass meadows, but there is limited knowledge on the interactive effects of nutrients under a changing climate, particularly for tropical seagrass species. This study aimed to detect the onset of stress...

Cite
Helber SB, Winters G, Stuhr M, et al. Nutrient History Affects the Response and Resilience of the Tropical Seagrass . Front Plant Sci. 2021;12:678341doi: 10.3389/fpls.2021.678341.
Helber, S. B., Winters, G., Stuhr, M., Belshe, E. F., Bröhl, S., Schmid, M., Reuter, H., & Teichberg, M. (2021). Nutrient History Affects the Response and Resilience of the Tropical Seagrass . Frontiers in plant science, 12678341. https://doi.org/10.3389/fpls.2021.678341
Helber, Stephanie B, et al. "Nutrient History Affects the Response and Resilience of the Tropical Seagrass ." Frontiers in plant science vol. 12 (2021): 678341. doi: https://doi.org/10.3389/fpls.2021.678341
Helber SB, Winters G, Stuhr M, Belshe EF, Bröhl S, Schmid M, Reuter H, Teichberg M. Nutrient History Affects the Response and Resilience of the Tropical Seagrass . Front Plant Sci. 2021 Aug 05;12:678341. doi: 10.3389/fpls.2021.678341. eCollection 2021. PMID: 34421939; PMCID: PMC8374242.
Copy Download .nbib Format: NLM
Oral efficacy of Δ(9)-tetrahydrocannabinol and cannabidiol in a mouse neuropathic pain model.

Neuropharmacology

Mitchell VA, Harley J, Casey SL, Vaughan AC, Winters BL, Vaughan CW.
PMID: 33741405
Neuropharmacology. 2021 May 15;189:108529. doi: 10.1016/j.neuropharm.2021.108529. Epub 2021 Mar 16.

The psychoactive and non-psychoactive constituents of cannabis, Δ9-tetrahydrocannabinol (THC) and cannabidiol (CBD), have synergistic analgesic efficacy in animal models of neuropathic pain when injected systemically. However, the relevance of this preclinical synergy to clinical neuropathic pain studies is unclear...

Cite
Mitchell VA, Harley J, Casey SL, et al. Oral efficacy of Δ(9)-tetrahydrocannabinol and cannabidiol in a mouse neuropathic pain model. Neuropharmacology. 2021;189:108529doi: 10.1016/j.neuropharm.2021.108529.
Mitchell, V. A., Harley, J., Casey, S. L., Vaughan, A. C., Winters, B. L., & Vaughan, C. W. (2021). Oral efficacy of Δ(9)-tetrahydrocannabinol and cannabidiol in a mouse neuropathic pain model. Neuropharmacology, 189108529. https://doi.org/10.1016/j.neuropharm.2021.108529
Mitchell, Vanessa A, et al. "Oral efficacy of Δ(9)-tetrahydrocannabinol and cannabidiol in a mouse neuropathic pain model." Neuropharmacology vol. 189 (2021): 108529. doi: https://doi.org/10.1016/j.neuropharm.2021.108529
Mitchell VA, Harley J, Casey SL, Vaughan AC, Winters BL, Vaughan CW. Oral efficacy of Δ(9)-tetrahydrocannabinol and cannabidiol in a mouse neuropathic pain model. Neuropharmacology. 2021 May 15;189:108529. doi: 10.1016/j.neuropharm.2021.108529. Epub 2021 Mar 16. PMID: 33741405.
Copy Download .nbib Format: NLM
Coagulation profile of human COVID-19 convalescent plasma.

Scientific reports

Klompas AM, van Helmond N, Juskewitch JE, Pruthi RK, Sexton MA, Soto JCD, Klassen SA, Senese KA, van Buskirk CM, Winters JL, Stubbs JR, Hammel SA, Joyner MJ, Senefeld JW.
PMID: 35022488
Sci Rep. 2022 Jan 12;12(1):637. doi: 10.1038/s41598-021-04670-1.

Convalescent plasma is used to treat COVID-19. There are theoretical concerns about the impact of pro-coagulant factors in convalescent plasma on the coagulation cascade particularly among patients with severe COVID-19. The aim of this study was to evaluate the...

Cite
Klompas AM, van Helmond N, Juskewitch JE, et al. Coagulation profile of human COVID-19 convalescent plasma. Sci Rep. 2022;12(1):637doi: 10.1038/s41598-021-04670-1.
Klompas, A. M., van Helmond, N., Juskewitch, J. E., Pruthi, R. K., Sexton, M. A., Soto, J. C. D., Klassen, S. A., Senese, K. A., van Buskirk, C. M., Winters, J. L., Stubbs, J. R., Hammel, S. A., Joyner, M. J., & Senefeld, J. W. (2022). Coagulation profile of human COVID-19 convalescent plasma. Scientific reports, 12(1), 637. https://doi.org/10.1038/s41598-021-04670-1
Klompas, Allan M, et al. "Coagulation profile of human COVID-19 convalescent plasma." Scientific reports vol. 12,1 (2022): 637. doi: https://doi.org/10.1038/s41598-021-04670-1
Klompas AM, van Helmond N, Juskewitch JE, Pruthi RK, Sexton MA, Soto JCD, Klassen SA, Senese KA, van Buskirk CM, Winters JL, Stubbs JR, Hammel SA, Joyner MJ, Senefeld JW. Coagulation profile of human COVID-19 convalescent plasma. Sci Rep. 2022 Jan 12;12(1):637. doi: 10.1038/s41598-021-04670-1. PMID: 35022488; PMCID: PMC8755772.
Copy Download .nbib Format: NLM
Showing 157 to 159 of 159 entries